Pascale Witz
CIK 1703723 · last filed 2026-05-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.78M
Companies
5
Total Filings
45
Lifetime Open-Market Net
-$247.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RVTY | Director | 15,985 | $111.51 | $1.78M | $0 | 4 | 2026-05-11 |
| Regulus Therapeutics Inc. (RGLS) Delisted | Director | 0 | $8.16 | $0 | $32.0K | 18 | 2025-06-27 |
| Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Director | 0 | $116.30 | $0 | $0 | 12 | 2023-10-06 |
| REVVITY, INC. (PKI) Delisted | Director | 7,360 | $115.24 | $848.2K | -$279.0K | 8 | 2022-05-09 |
| TESARO, Inc. (TSRO) Delisted | Director | 0 | — | — | $0 | 3 | 2019-01-22 |
Recent Filings · Page 2 of 5
45 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-13 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-17 | RVTY | Grant (A) | +1,738 | $0 | EDGAR |
| 2023-05-02 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Mixed | +2,034 | -$208.9K | EDGAR |
| 2022-06-10 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-09 | REVVITY, INC. (PKI) Delisted | Grant (A) | +1,354 | $0 | EDGAR |
| 2022-05-02 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Mixed | +2,565 | -$163.4K | EDGAR |
| 2021-06-15 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-10 | REVVITY, INC. (PKI) Delisted | Grant (A) | +1,313 | $0 | EDGAR |
| 2021-04-30 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Mixed | +6,741 | -$412.3K | EDGAR |
| 2020-08-04 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Mixed | +4,983 | -$197.1K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.